Bausch Health Companies | VRX - Trade Debtors


Bausch Health Companies reported $2.19B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Amgen USD 9.14B 432M Mar/2026
ANI Pharmaceuticals USD 255.43M 25.65M Mar/2026
Aurora Cannabis CAD 48.26M 1.53M Dec/2025
Bausch Health Companies USD 2.19B 160M Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Canopy Growth CAD 140.42M 113.56M Dec/2025
Corcept Therapeutics USD 39.07M 20.71M Mar/2026
Danaher USD 4.76B 845M Mar/2026
Drreddys Laboratories INR 1.41B 11.6M Dec/2025
Eli Lilly USD 21.18B 1.02B Mar/2026
Gilead Sciences USD 4.74B 172M Mar/2026
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Novo Nordisk DKK 106.26B 11.21B Mar/2026
Pacira USD 125.64M 1.57M Mar/2026
Perrigo USD 697.1M 84.3M Mar/2026
Phibro Animal Health USD 215.87M 2.02M Dec/2025
Prestige Brands USD 191.92M 1.46M Mar/2026
Supernus Pharmaceuticals USD 182.18M 5.62M Mar/2026
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026
Zoetis USD 1.51B 84M Mar/2026